Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Alector stock in Canada | $36.91
Own Alector shares in just a few minutes.
Alector (ALEC) is a leading biotechnology business based in the US. It opened the day at $39.6 after a previous close of $39.13. During the day the price has varied from a low of $35.57 to a high of $39.74. The latest price was $36.91 (25 minute delay). Alector is listed on the NASDAQ and employs 181 staff. All prices are listed in US Dollars.
How to buy Alector stock in Canada
- Choose a platform. If you're a beginner, our stock trading table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: ALEC in this case.
- Research Alector stocks. The platform should provide the latest information available.
- Buy your Alector stocks. It's that simple.
What's in this guide?
- Can I buy shares in Alector?
- Has coronavirus impacted Alector shares?
- Alector shares summary
- Compare share dealing platforms
- Is Alector stock a buy or sell?
- Alector performance over time
- Can I short Alector shares?
- Alector's financials
- How volatile are Alector shares?
- Does Alector pay a dividend?
- Other common questions
How has Coronavirus impacted Alector's stock price?
Since the stock market crash in March caused by coronavirus, Alector's stock price has had significant negative movement.
Its last market close was $17.8, which is 41.58% down on its pre-crash value of $30.47 and 16.01% down on the lowest point reached during the March crash when the stocks fell as low as $20.65.
If you had bought $1,000 worth of Alector stocks at the start of February 2020, those stocks would have been worth $844.54 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $631.37.
Alector stock priceUse our graph to track the performance of ALEC stocks over time.
Alector stocks at a glance
|52-week range||$9.12 - $39.74|
|50-day moving average||$27.524|
|200-day moving average||$20.5391|
|Wall St. target price||$38.75|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.255|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Alector stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Alector price performance over time
|1 month (2021-07-02)||4.83%|
|3 months (2021-05-03)||95.50%|
|Revenue TTM||USD$18 million|
|Gross profit TTM||USD$-135,771,000|
|Return on assets TTM||-24.25%|
|Return on equity TTM||-65.33%|
|Market capitalisation||USD$2.4 billion|
TTM: trailing 12 months
How to short and sell Alector stocks
- Create a CFD or spread betting account.
- Search for the stock code. E.g. "ALEC.US"
- Choose your position size.
- Select "sell" rather than "buy".
- Confirm your position and keep tabs on it. You may wish to set limits on your position.
There are currently 6.2 million Alector stocks held short by investors – that's known as Alector's "short interest". This figure is 16.6% down from 7.4 million last month.
There are a few different ways that this level of interest in shorting Alector stocks can be evaluated.
Alector's "short interest ratio" (SIR)
Alector's "short interest ratio" (SIR) is the quantity of Alector stocks currently shorted divided by the average quantity of Alector stocks traded daily (recently around 3.0 million). Alector's SIR currently stands at 2.09. In other words for every 100,000 Alector stocks traded daily on the market, roughly 2090 stocks are currently held short.
However Alector's short interest can also be evaluated against the total number of Alector stocks, or, against the total number of tradable Alector stocks (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Alector's short interest could be expressed as 0.08% of the outstanding stocks (for every 100,000 Alector stocks in existence, roughly 80 stocks are currently held short) or 0.1194% of the tradable stocks (for every 100,000 tradable Alector stocks, roughly 119 stocks are currently held short).
Such a low SIR usually points to an optimistic outlook for the stock price, with fewer people currently willing to bet against Alector.
Find out more about how you can short Alector stock.
Alector stock dividends
We're not expecting Alector to pay a dividend over the next 12 months. However, you can browse other dividend-paying stocks in our guide.
Alector stock price volatility
Over the last 12 months, Alector's stocks have ranged in value from as little as $9.12 up to $39.74. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while Alector's is 1.0437. This would suggest that Alector's stocks are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The company also offers AL002, a product candidate that is in Phase II clinical trial for the treatment of Alzheimer's disease; and AL003, which is in Phase Ib clinical trial for the treatment of Alzheimer's disease. In addition, its products in development stage include AL044 that targets MS4A4A, a risk gene for Alzheimer's disease; and 8 candidates in immuno-neurology/immuno-oncology field comprise ADP012, ADP016, ADP017, ADP023, ADP026, ADP122, ADP009, and ADP022. Alector, Inc. has a collaboration agreement with Adimab, LLC for the research and development of antibodies. The company was founded in 2013 and is headquartered in South San Francisco, California.
Stocks similar to Alector
Alector in the news
Alector selloff on AL001 readout surprising, says H.C. Wainwright
70 Biggest Movers From Yesterday
Alector Presents 12-Month Results from the INFRONT-2 Phase 2 Open-label Clinical Study of AL001 for the Treatment of Symptomatic Frontotemporal Dementia Patients with a Progranulin Mutation
Frequently asked questions
More guides on Finder
How to buy Wheels Up (UP) stock in Canada when it goes public
Everything we know about the Wheels Up IPO, plus information on how to buy in.
How to invest $1 million
Here are the top 5 ways you should invest $1 million.
How to buy Brookfield Asset Management Reinsurance Partners Ltd (BAMR) stock in Canada when it goes public
Everything we know about the Brookfield Asset Management Reinsurance Partners Ltd IPO, plus information on how to buy in.
How to buy Traeger (COOK) stock in Canada
Everything we know about the Traeger IPO, plus information on how to buy in.
How to buy Teads (TEAD) stock in Canada when it goes public
Everything we know about the Teads IPO, plus information on how to buy in.
How to buy Snap One Holdings Corp (SNPO) stock in Canada
Everything we know about the Snap One Holdings Corp IPO, plus information on how to buy in.
How to buy Riskified (RSKD) stock in Canada
Everything we know about the Riskified IPO, plus information on how to buy in.
How to buy Preston Hollow Community Capital (PHCC) stock in Canada when it goes public
Everything we know about the Preston Hollow Community Capital IPO, plus information on how to buy in.
How to buy PowerSchool Holdings (PWSC) stock in Canada
Everything we know about the PowerSchool Holdings IPO, plus information on how to buy in.
How to buy MeridianLink (MLNK) stock in Canada
Everything we know about the MeridianLink IPO, plus information on how to buy in.
Ask an Expert
You must be logged in to post a comment.